Novel phage derived antimicrobials
Beschreibung
Novel, patentable bacteriophage-based precision antimicrobials are generated. To minimize the risk of failure at the pre-clinical stage, in vivo activity screening in zebrafish embryos is combined with process development, continuous evolution, and phage engineering during early stages of discovery.
Eckdaten
Projektleitung
Stellv. Projektleitung
Projektteam
Projektpartner
Micreos GmbH
Projektstatus
laufend, gestartet 08/2023
Institut/Zentrum
Institut für Chemie und Biotechnologie (ICBT); Institut für Lebensmittel- und Getränkeinnovation (ILGI)
Drittmittelgeber
Innovationsprojekt / Projekt Nr. 104.969 IP-LS
Einsiedlerstrasse 31
8820 Wädenswil